Extended-interval gentamicin administration in neonates: a simplified approach
G M El-Chaar1,2, T Supaswud-Franks3, L Venugopalan4
1Department of Clinical Health Professions, St John's University College of Pharmacy and Health Sciences, Jamaica, NY, USA.
Summary
A new, uniform gentamicin dose for all neonates significantly reduced elevated trough levels, proving safe and effective. This simplified dosing strategy improves therapeutic outcomes and reduces healthcare costs.
Area of Science:
- Neonatal pharmacology
- Pediatric infectious diseases
- Clinical pharmacy
Background:
- Gentamicin dosing in neonates is complex and often leads to suboptimal serum levels.
- Traditional dosing regimens frequently result in elevated trough serum gentamicin levels, increasing the risk of nephrotoxicity and ototoxicity.
- There is a need for a simplified and effective gentamicin dosing strategy in the neonatal population.
Purpose of the Study:
- To evaluate the efficacy of a uniform gentamicin dose in reducing elevated trough serum gentamicin levels in neonates of all gestational ages.
- To compare the incidence of elevated trough levels between a standardized dosing regimen and traditional dosing.
- To assess the safety and therapeutic range achievement of the standardized gentamicin dose.
Main Methods:
- A prospective, randomized, controlled trial was conducted with neonates divided into two groups based on gestational age.
- The study arm received a uniform gentamicin dose of 5 mg/kg intravenously every 36 hours.
- The control arm received traditional gentamicin dosing. Serum gentamicin levels, infection resolution, and adverse effects were monitored.
Main Results:
- Elevated trough gentamicin levels were significantly reduced by 66% in neonates with gestational age ≤34 6/7 weeks and by 100% in those >35 0/7 weeks.
- In the study arm, 48/49 neonates achieved target trough serum gentamicin concentrations (<2 mg/L), with most below 1 mg/L.
- The standardized dose led to a 50% reduction in dosage modifications and demonstrated no treatment failures or adverse effects.
Conclusions:
- A standardized gentamicin dosage of 5 mg/kg IV every 36 hours is safe and effective for neonates of all gestational ages.
- This simplified dosing strategy achieves therapeutic serum gentamicin concentrations, reduces the incidence of elevated trough levels, and minimizes dosage adjustments.
- Implementing this uniform dosing can decrease healthcare costs through less frequent administration and reduced medication errors associated with complex dosing schemes.
Related Concept Videos
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
317
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
317
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
334
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
334
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
369
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
01:29Drug Dosing: Infants and Children
720
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
720
01:20Estimation of k and VD of Aminoglycosides
297
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
297
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
678
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678